Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000903112-97-000463
Filing Date
1997-03-20
Accepted
1997-03-20 00:00:00
Documents
6
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10K 10-K 239175
2 CERTIFICATE OF AMENDMENT EX-3.3 2405
3 NET LOSS PER SHARE EX-11.1 11542
4 RESEARCH AGREEMENT EX-10.15 33745
5 CONSENT OF INDEPENDENT AUDITORS EX-23.1 674
6 ART.5 FDS EX-27 1821
  Complete submission text file 0000903112-97-000463.txt   291302
Mailing Address C/O BATTLE FOWLER LLP 75 EAST 55TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH ST NEW YORK NY 10022 2124310001
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

EIN.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21990 | Film No.: 97559843
SIC: 2836 Biological Products, (No Diagnostic Substances)